Financial reports
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
2 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
14 Mar 22
Current reports
8-K
Other Events
2 Apr 24
8-K
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
27 Feb 24
8-K
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
29 Nov 23
8-K
Other Events
13 Nov 23
8-K
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
7 Nov 23
8-K
Other Events
23 Oct 23
8-K
Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results
10 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
16 Jun 23
8-K
Entry into a Material Definitive Agreement
15 Jun 23
8-K
Verve Therapeutics Announces Pipeline Progress and Expansion and Reports First Quarter 2023 Financial Results
15 May 23
Registration and prospectus
S-8
Registration of securities for employees
27 Feb 24
424B5
Prospectus supplement for primary offering
29 Nov 23
424B5
Prospectus supplement for primary offering
28 Nov 23
S-8
Registration of securities for employees
2 Mar 23
S-3ASR
Automatic shelf registration
23 Sep 22
424B5
Prospectus supplement for primary offering
21 Jul 22
424B5
Prospectus supplement for primary offering
20 Jul 22
S-3
Shelf registration
1 Jul 22
S-8
Registration of securities for employees
14 Mar 22
S-8
Registration of securities for employees
17 Jun 21
Other
EFFECT
Notice of effectiveness
13 Jul 22
EFFECT
Notice of effectiveness
17 Jun 21
SEC STAFF
SEC staff action: Order
16 Jun 21
CERT
Certification of approval for exchange listing
15 Jun 21
CORRESP
Correspondence with SEC
14 Jun 21
CORRESP
Correspondence with SEC
14 Jun 21
CORRESP
Correspondence with SEC
4 Jun 21
CORRESP
Correspondence with SEC
28 May 21
SEC STAFF
SEC staff action: Order
13 May 21
UPLOAD
Letter from SEC
13 May 21